John B. Buse

Research interests

Publications

• Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection

  JAMA · 2023 · https://doi.org/10.1001/jama.2023.8823

• Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

  Diabetes Care · 2022 · https://doi.org/10.2337/dci22-0034

• Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

  Diabetologia · 2022 · https://doi.org/10.1007/s00125-022-05787-2

• Glucose-responsive insulin patch for the regulation of blood glucose in mice and minipigs

  Nature Biomedical Engineering · 2020 · https://doi.org/10.1038/s41551-019-0508-y

• 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

  Diabetes Care · 2019 · https://doi.org/10.2337/dci19-0066

• Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

  Diabetes Care · 2018 · 10.2337/dci18-0033

• Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

  Diabetologia · 2018 · 10.1007/s00125-018-4729-5

• Liraglutide and Renal Outcomes in Type 2 Diabetes

  New England Journal of Medicine · 2017 · 10.1056/nejmoa1616011

• Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes

  New England Journal of Medicine · 2017 · 10.1056/nejmoa1612917

• Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

  New England Journal of Medicine · 2016 · 10.1056/nejmoa1603827

• Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

  New England Journal of Medicine · 2015 · 10.1056/nejmoa1501352

• Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

  Diabetes Care · 2014 · 10.2337/dc14-2441

• Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

  Diabetes Care · 2012 · 10.2337/dc12-0413

• Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

  Diabetologia · 2012 · 10.1007/s00125-012-2534-0

• Strategies for Multivessel Revascularization in Patients with Diabetes

  New England Journal of Medicine · 2012 · 10.1056/nejmoa1211585

• The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study

  BMJ · 2010 · 10.1136/bmj.b4909

• Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes

  New England Journal of Medicine · 2010 · 10.1056/nejmoa1002853

• How Do We Define Cure of Diabetes?

  Diabetes Care · 2009 · 10.2337/dc09-9036

• Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)

  The Lancet · 2009 · 10.1016/s0140-6736(09)60659-0

• Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study

  The Lancet · 2008 · 10.1016/s0140-6736(08)61206-4

• Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials

  Diabetes Care · 2008 · 10.2337/dc08-9026

• Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy

  Diabetes Care · 2008 · 10.2337/dc08-9025

• Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy

  Diabetes Care · 2006 · 10.2337/dc06-9912

• Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus

  Diabetes Care · 2006 · 10.2337/dc07-9917

• The Metabolic Syndrome: Time for a Critical Appraisal

  Diabetes Care · 2005 · 10.2337/diacare.28.9.2289

• Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Sulfonylurea-Treated Patients With Type 2 Diabetes

  Diabetes Care · 2004 · 10.2337/diacare.27.11.2628

Current projects

No projects listed.